rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    RGC
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Regencell Bioscience stock hits 52-week low at $4.50
      Nov 17Investing.comRGC
      Regencell Bioscience Holdings (RGC) Stock Looks Rich After A Very Large Run

      Regencell Bioscience Holdings has seen a very large share price gain over the past three years, yet recent weakness now has investors asking whether the current US$5.63 level still lines up with the business on a simple book value basis. With such a sharp swing in the recent share price record, the central issue is how much of the move book equity can reasonably support. Over the last three years the stock has delivered a return of more than 10x. This puts a lot of weight on the question of...

      Nov 10Yahoo FinanceRGC
      Regencell (RGC) Stock Looks Rich As DOJ Probe Raises Questions

      Regencell Bioscience Holdings has seen its share price swing sharply in recent years, which puts fresh focus on whether the current US$7.67 level lines up with what its balance sheet and book value can support. With the spotlight back on the stock after a series of setbacks and scrutiny, the key issue for you is how that market price stacks up against what the business has actually built up in net assets. Over the past 5 years the stock has delivered a very large gain of about 20 times,...

      Oct 25Yahoo FinanceRGC
      How Investors Are Reacting To Regencell Bioscience Holdings (RGC) Wider Full Year Loss
      Oct 17Yahoo FinanceRGC
      12 Health Care Stocks Moving In Thursday's Intraday Session
      Oct 15BenzingaRGC
      Is Regencell Bioscience Holdings (RGC) Fully Priced After Its Annual Loss Deepened?
      Oct 8Yahoo FinanceRGC
      Regencell Bioscience: I Got It Wrong (Rating Downgrade) (NASDAQ:RGC)
      Sep 23Seeking AlphaRGC

      This is the newest page. Registered accounts read further back.